Date | Time | Source | Headline | Symbol | Company |
07/08/2024 | 1:53PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SCLX | Scilex Holding Company |
07/02/2024 | 5:15PM | GlobeNewswire Inc. | Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination | NASDAQ:SCLX | Scilex Holding Company |
07/02/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York | NASDAQ:SCLX | Scilex Holding Company |
07/01/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024 | NASDAQ:SCLX | Scilex Holding Company |
06/20/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC. | NASDAQ:SCLX | Scilex Holding Company |
06/14/2024 | 1:41PM | GlobeNewswire Inc. | Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica) | NASDAQ:SCLX | Scilex Holding Company |
06/13/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024 | NASDAQ:SCLX | Scilex Holding Company |
06/12/2024 | 3:37PM | AllPennyStocks.com | Pharma Shares Pop After Securing $100M Of Financing | NASDAQ:SCLX | Scilex Holding Company |
06/11/2024 | 7:20PM | GlobeNewswire Inc. | Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies | NASDAQ:SCLX | Scilex Holding Company |
06/11/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA® | NASDAQ:SCLX | Scilex Holding Company |
06/10/2024 | 11:49AM | GlobeNewswire Inc. | Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S. | NASDAQ:SCLX | Scilex Holding Company |
06/06/2024 | 2:56PM | GlobeNewswire Inc. | Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024 | NASDAQ:SCLX | Scilex Holding Company |
05/30/2024 | 1:19PM | GlobeNewswire Inc. | Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company | NASDAQ:SCLX | Scilex Holding Company |
05/24/2024 | 1:40PM | GlobeNewswire Inc. | Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index | NASDAQ:SCLX | Scilex Holding Company |
05/24/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company | NASDAQ:SCLX | Scilex Holding Company |
05/14/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine Pro | NASDAQ:SCLX | Scilex Holding Company |
05/13/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock | NASDAQ:SCLX | Scilex Holding Company |
04/25/2024 | 4:01PM | GlobeNewswire Inc. | Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering | NASDAQ:SCLX | Scilex Holding Company |
04/24/2024 | 8:00AM | GlobeNewswire Inc. | Scilex Holding Company Announces $15 Million Registered Direct Offering | NASDAQ:SCLX | Scilex Holding Company |
04/16/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Ad | NASDAQ:SCLX | Scilex Holding Company |
04/09/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool | NASDAQ:SCLX | Scilex Holding Company |
03/27/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend | NASDAQ:SCLX | Scilex Holding Company |
03/21/2024 | 9:30AM | GlobeNewswire Inc. | Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients | NASDAQ:SCLX | Scilex Holding Company |
03/20/2024 | 11:00AM | GlobeNewswire Inc. | Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed | NASDAQ:SCLX | Scilex Holding Company |
03/20/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchic | NASDAQ:SCLX | Scilex Holding Company |
03/19/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation | NASDAQ:SCLX | Scilex Holding Company |
03/18/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in | NASDAQ:SCLX | Scilex Holding Company |
03/15/2024 | 2:45PM | GlobeNewswire Inc. | Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc. | NASDAQ:SCLX | Scilex Holding Company |
03/15/2024 | 9:00AM | GlobeNewswire Inc. | Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of S | NASDAQ:SCLX | Scilex Holding Company |
03/11/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:SCLX | Scilex Holding Company |